BeiGene
ONC
#685
Rank
NZ$48.41 B
Marketcap
$427.94
Share price
2.82%
Change (1 day)
76.26%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (ONC)

Market cap: NZ$48.41 Billion

As of April 2025 BeiGene has a market cap of NZ$48.41 Billion. This makes BeiGene the world's 685th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$48.41 B33.31%
2024NZ$36.31 B16.5%
2023NZ$31.17 B-22.18%
2022NZ$40.05 B-1.55%
2021NZ$40.68 B24.04%
2020NZ$32.80 B116.22%
2019NZ$15.17 B21.77%
2018NZ$12.45 B98.83%
2017NZ$6.26 B260.33%
2016NZ$1.73 B

End of Day market cap according to different sources

On Apr 24th, 2025 the market cap of BeiGene was reported to be:

NZ$45.67 Billion
by Nasdaq info icon info icon
NZ$49.77 Billion
by CompaniesMarketCap info icon info icon
NZ$49.77 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$34.92 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.93 B-96.00%๐Ÿ‡บ๐Ÿ‡ธ USA